The Surgeon General's Report on Mental Health

Contents | Order | Resources | Report Home | Site Home

Chapter 2: The Fundamentals of Mental Health and Mental Illness

• Table 2-1. Selected neurotransmitters important in psychopharmacology
• Table 2-2. Common signs of acute anxiety
• Table 2-3. Common manifestations of schizophrenia
• Table 2-4. Common signs of mood disorders
• Table 2-5. Major diagnostic classes of mental disorders (DSM-IV)
• Table 2-6. Best estimate 1-year prevalence rates based on ECA and NCS, ages 18–54
• Table 2-7. Children and adolescents ages 9 to 17 with mental or addictive disorders, combined MECA sample
• Table 2-8. Best estimate prevalence rates based on Epidemiologic Catchment Area, age 55+
• Table 2-9. Selected types of pharmacotherapies
• Table 2-10. Historical reform movements in mental health treatment in the United States
• Figure 2-1. Structural variety of neurons
• Figure 2-2. How neurons communicate
• Figure 2-3. The brain: Organ of the mind
• Figure 2-4. The mental health service system
• Figure 2-5a. Annual prevalence of mental/addictive disorders and services for adults
• Figure 2-5b. Annual prevalence of mental/addictive disorders and services for adults
• Figure 2-6a. Annual prevalence of mental/addictive disorders for children
• Figure 2-6b. Annual prevalence of mental/addictive disorders for children
• Figure 2-7. Definitions of recovery from consumer writings

Chapter 3: Children and Mental Health

• Table 3-1. Children and adolescents age 9–17 with mental or addictive disorders, combined MECA sample, 6-month (current) prevalence
• Table 3-2. Selected mental disorders of childhood and adolescence from the DSM-IV
• Table 3-3. DSM-IV diagnostic criteria for attention-deficit/hyperactivity disorder
• Figure 3-1. Questionnaires used to assess childhood mood disorders
• Figure 3-2. Grading the level of evidence for efficacy of psychotropic drugs in children

Chapter 4: Adults and Mental Health

• Table 4-1. Best estimate 1-year prevalence based on ECA and NCS, ages 18–54
• Table 4-2. DSM-IV diagnostic criteria for major depressive episode
• Table 4-3. DSM-IV diagnostic criteria for dysthymic disorder
• Table 4-4. DSM-IV diagnostic criteria for manic episode
• Table 4-5. DSM-IV diagnostic criteria for cyclothymic disorder
• Table 4-6. DSM-IV diagnostic criteria for schizophrenia
• Table 4-7. Positive and negative symptoms of schizophrenia
• Table 4-8. Selected treatment recommendations, Schizophrenia Patient Outcomes Research Team
• Figure 4-1. Surgeon General’s Call to Action to Prevent Suicide—1999
• Figure 4-2. Treatment of depression—newer pharmacotherapies: Summary findings.
• Figure 4-3. Risk of developing schizophrenia.

Chapter 5: Older Adults and Mental Health

• Table 5-1. Best estimate 1-year prevalence rates based on Epidemiologic Catchment Area, age 55+
• Table 5-2. Settings for mental health services for older adults
• Figure 5-1. Increases in the percent of the U.S. population over age 65 years and over age 85 years
• Figure 5-2. Neuritic plaques and many neurofibrillary tangles in the hippocampus of an Alzheimer’s disease patient.

Chapter 6: Organizing and Financing Mental Health Services

• Table 6-1. Proportion of adult population using mental/addictive disorder services in one year
• Table 6-2. Proportion of child/adolescent populations (ages 9–17) using mental/addictive disorder services in one year
• Table 6-3. Distribution of 1996 U.S. population and mental disorder direct costs by insurance status
• Table 6-4. Population, spending, and per capita mental health costs by insurance status (1996)
• Table 6-5. Mental health expenditures in relation to national health expenditures, by source of payer, annual growth rate (1986–1996)
• Table 6-6. Mental health expenditures in relation to national health expenditures, by source of payer, 1996
• Figure 6-1. Annual prevalence of mental/addictive disorders and services for adults
• Figure 6-2. Annual prevalence of mental/addictive disorders and services for children
• Figure 6-3. Global burden of disease—DALYs worldwide—1990
• Figure 6-4. 1996 National Health Accounts, $943 billion total—$99 billion mental, addictive, and dementia disorders.
• Figure 6-5. 1996 National Health Accounts, $69 billion total mental health expenditures by provider type.
• Figure 6-6. Mental health expenditures by payer—1996 (total = $69 billion)

---